『Psychedelic Medicine Podcast with Dr. Lynn Marie Morski』のカバーアート

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski

著者： Lynn Marie Morski MD JD
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
Curious about the possible therapeutic benefits of psychedelic medicines? The Psychedelic Medicine Podcast with Dr. Lynn Marie Morski has you covered with the latest in scientific research, medical practices, and legal developments involving these substances and their incredible therapeutic potential. Covering the full range of psychedelic therapies, including psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and more, this podcast serves as an auditory encyclopedia of information for anyone interested in learning about the safe, therapeutic uses of these medicines.All podcast episodes and show notes are copyright Lynn Marie Morski, 2025. 心理学 心理学・心の健康 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Psilocybin for PTSD with Stacey Armstrong, PhD

    Psilocybin for PTSD with Stacey Armstrong, PhD
    2026/10/07
    In this episode of the Psychedelic Medicine Podcast, Stacey Armstrong, PhD joins to discuss the latest research on psilocybin treatments for PTSD. Dr. Armstrong is Associate Director and Senior Researcher at The Ohio State University's Center for Psychedelic Drug Research and Education, and a clinical psychologist with advanced training in treating PTSD in veterans. She is the first author on a recent pilot study of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD. In this conversation, Dr. Armstrong discusses her team's pilot study of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD, explaining why this population urgently needs new treatment options and how trauma, repeated exposure, military culture, and difficulties with reintegration may contribute to the severity and persistence of PTSD among veterans. Dr. Armstrong emphasizes that the potential benefits of psilocybin cannot be separated from the therapeutic context, including extensive preparation, trust-building, supportive care during dosing, and integration focused on psychological flexibility and personal values. The conversation explores how psilocybin may create a window for new ways of thinking and behaving, why preparation itself appeared to contribute to symptom improvement, and what larger, controlled and more diverse studies will need to investigate before psilocybin-assisted therapy can become a more established treatment for PTSD. In this episode, you'll hear: Why veterans with PTSD may experience particularly severe, chronic, and treatment-resistant symptomsHow trauma, military culture, and difficulties transitioning back to civilian life can complicate PTSD treatmentThe preliminary findings from Dr. Armstrong's pilot study of psilocybin-assisted therapy in 12 veteransHow the study used four extended preparation sessions and two ascending-dose psilocybin sessions to build trust and gradually introduce participants to the psychedelic experienceHow acceptance and commitment therapy themes, psychological flexibility, and values informed the preparation and integration processWhat future research should investigate, including larger controlled trials, longer-term outcomes, more diverse participants, and the potential therapeutic effects of preparation alone Quotes: "[Dr. Morski] What do you think the mechanism of action of why psilocybin might be effective in treating PTSD? [Dr. Armstrong] That's a great question. You know we don't know for sure. That's the straightforward short answer. But there are some hypotheses right. So there seems to be some impacts at the mechanistic biological level, some some changes in brain functioning from what we can tell that perhaps it opens up an opportunity, psilocybin itself, to be able to think in new ways or or perhaps not foreclose on a coping strategy that maybe before I would have been like, no way. I'm absolutely not going to go into that triggering, you know, grocery store at the busiest time on Saturday. So it might create a window of opportunity to basically try out and create new pathways in the brain of ways to think. And, and maybe we feel a little bit different when we're doing things because of these new ways our brain is functioning. But at the same time, you know, there seems to be something important—or at least I feel pretty compelled—that there's something happening psychologically as well. So a lot of the hype and the excitement—of course, and understandably—goes towards the psychedelic itself: like what's happening with the psychedelic and why is it creating better outcomes for some people. But I think there's a really important piece of the story too, which is: it's a therapy and it's a therapy around what we're doing to prepare somebody for a psychedelic experience and how we're showing up for them during a psychedelic dosing session. So, you know, we don't just put them in a room and walk away and we're there. We're with them for the whole day, making sure they don't need anything. If they're feeling anxious, they're having a hard time. You know, we're there to help support them throughout that process, but then also to kind of put the pieces together on the other side, which is this integration piece. And there seems to be something perhaps quite compelling about this complete picture." [12:14 - 14:47] "Psilocybin when taken at high enough doses can create an experience that can change drastically one's perception of themselves, other people in the world. And so there often are experiences that people are having during a dosing session that can be leveraged in integration, for instance, to help somebody take advantage of that biological window of opportunity. So they're saying like, 'man, I had this really, really significant insight about my trauma,' right? 'I essentially felt a profound sense of forgiveness that I've never felt before. And now I know what that feels like.' And so then we go into the ...
    続きを読む 一部表示
    37 分
  • Extended Post-Psychedelic Difficulties with Christian Jurlando, PhD

    Extended Post-Psychedelic Difficulties with Christian Jurlando, PhD
    2026/09/23
    In this episode of the Psychedelic Medicine Podcast, Christian Jurlando, PhD, joins to unpack the topic of extended difficulties following psychedelic experiences. Dr. Jurlando is a humanities professor at Stevens Institute of Technology in Hoboken, NJ, and a researcher and advocate focused on psychedelic safety and extended post-psychedelic difficulties (EPPD). Drawing in part on his own lived experience of prolonged difficulties following psilocybin use, his work focuses on improving recognition, care, and support for people experiencing adverse psychedelic outcomes. In this conversation, Dr. Jurlando discusses extended post-psychedelic difficulties, drawing on both research and his own experience of EPPD following a low dose of psilocybin. He explains that these difficulties can take many forms, may occur even after relatively small doses, and can persist long after the acute psychedelic experience has ended. The conversation explores how to distinguish acute crises and shorter-term difficulties from extended post-psychedelic difficulties, as well as the importance of recognizing when someone needs professional support. Dr. Jurlando also discusses the emerging infrastructure for supporting people who experience adverse psychedelic outcomes, including peer support, harm-reduction services, specialized clinics, and the development of clearer pathways for escalation and referral. Throughout, he emphasizes the importance of acknowledging these experiences within the psychedelic field, developing more nuanced approaches to risk and informed consent, and recognizing that recovery can take time and may involve different approaches for different people. In this episode, you'll hear: What extended post-psychedelic difficulties can look like and how they may differ from psychosis or other acute psychedelic complications Four questions for assessing whether someone experiencing post-psychedelic difficulties may need additional support How peer-support and harm-reduction services can identify when someone may need to be referred for more specialized care What is currently known about risk factors, set and setting, and the prevalence of extended post-psychedelic difficulties Why psychedelic risk needs to be considered in relation to the potential benefits and the individual circumstances of each patient Quotes: "In my research, I found that back in the late 50s, that was kind of the rule of thumb: that smaller doses were more dangerous because people didn't process what was coming up and could get stuck in a negative state." [5:16] "The best estimate [of extended post-psychedelic difficulties] that we have right now is from the Global Psychedelic Survey… over 6400 people were surveyed and 8% reported difficulties lasting a month or longer that meaningfully disrupted their daily functioning." [10:43] "It's very difficult when something presents so fast to realize that the remedy or getting better takes time. It takes, in fact, sometimes a lot of time. And there can be a lot of resistance to that because you think 'hey, if I just took some mushrooms and then suddenly felt this way, surely I can just take something else and suddenly feel better, right?' It doesn't work that way. And so I think that that's sort of an added level of distress, and it's maybe unique." [13:59] "What we're finding is that what people really need is just acknowledgment that these sorts of things happen. That's the first thing that would have been really helpful for me—because when you're in that state and you think that you've broken your brain or something, then it can just start snowballing." [17:37] "It does seem like there's a wide variety of treatments [for extended post-psychedelic difficulties] and some work for some [people] and some work for others." [32:05] Links: Dr. Jurlando on LinkedIn Dr. Jurlando's article: "The invention of challenging psychedelic experiences: Meaning, measurement, and foreclosure of extended harm" Dr. Jurlando's article (pre-print): "Strengthening the Psychedelic Safety Net: A Call for a Coordinated Ecosystem of Post-Psychedelic Care" Challenging Psychedelic Experiences Project website Fireside Project website Previous episode: The Challenging Psychedelic Experiences Project with Jules Evans Previous episode: Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD Psychedelic Medicine Association Porangui
    続きを読む 一部表示
    34 分
  • Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

    Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych
    2026/09/09

    In this episode of the Psychedelic Medicine Podcast, Nigel Denning, MA, MPsych, joins to discuss the reasons profound psychedelic experiences don't always lead to lasting change. Nigel is a Counselling Psychologist and Director of Integrative Psychology & Medicine, with nearly 40 years of experience working with psychedelic and non-ordinary states. He has trained with MAPS, and served as co-lead therapist on three psychedelic clinical trials.

    In this conversation, Nigel emphasizes the importance of preparation, integration, and creating the conditions for new experiences to become part of everyday life for effective psychedelic therapy. He explains that psychedelic sessions can open a period of neuroplasticity, but that without adequate reinforcement, people may naturally return to familiar patterns and ways of understanding themselves. Nigel discusses his three-phase approach to integration, which begins with simply becoming familiar with the experience, moves into narrating and embodying it, and ultimately arrives at meaning-making. He also highlights the importance of somatic awareness, curiosity, breathwork, and stabilization in helping people integrate experiences without prematurely imposing intellectual interpretations. Throughout the conversation, Nigel cautions against rushing back into ordinary routines or repeatedly pursuing psychedelic states in search of a lasting transformation, instead encouraging people to give new experiences time and space to become woven into their everyday life.

    In this episode, you'll hear:

    • The importance of preparation and setting realistic expectations before a psychedelic experience
    • Why curiosity is more useful than trying to control or rush to interpret what happens during a session
    • How somatic awareness and breathwork can help integrate psychedelic experiences
    • Why integration requires stabilization and creating space after an experience
    • Why it's never too late to begin integrating a psychedelic experience from the past
    • The risks of "state change chasing" and repeatedly pursuing psychedelic experiences instead of integrating them

    Quotes:

    "[Psychedelic therapy] is a very different way of intervening psychologically. You're really preparing someone to be curious about anything that arises so that they're not going in with expectations that this is going to be this incredibly wonderful experience that's just going to change their life—it might be a really awful experience—but that as long as you can make meaning of it as you're coming out of it, that's where the transformation comes." [5:28]

    "We can't predict, we can't shape and control what happens in the session. Therefore, let's just get really curious. Let's learn how to breathe and slow down and relax ourselves into meeting anything that emerges." [6:11]

    "The real meaning, the real return to subjectivity, is part of the integration process" [7:21]

    "[Integration] is all about familiarizing the unfamiliar without racing into a top-down reduction of it into a thing that meant this." [21:45]

    "It's amazing how stabilizing the breath can be. If you're in the depths of a psychedelic hell-world and you've got no perspective on anything, what you can still do is breathe. … that quality of centering in the breath creates then that capacity to at least remember you have a body." [27:21]

    Links:

    Nigel on LinkedIn

    Integrative Psychology & Medicine website

    Integrative Psychology & Medicine on Instagram

    Psychedelic Medicine Association

    Porangui
    続きを読む 一部表示
    36 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません